Empagliflozin in patients admitted to hospital with COVID-19 (Recovery): a randomised controlled, open-label, platform trial

RECOVERY Collaborative Group

Research output: Contribution to journalArticlepeer-review

14 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Empagliflozin in patients admitted to hospital with COVID-19 (Recovery): a randomised controlled, open-label, platform trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science